712 related articles for article (PubMed ID: 16580609)
21. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
Gao C; Higgins PJ; Zhang W
Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
[TBL] [Abstract][Full Text] [Related]
22. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.
Kamsteeg EJ; Wormhoudt TA; Rijss JP; van Os CH; Deen PM
EMBO J; 1999 May; 18(9):2394-400. PubMed ID: 10228154
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
24. Molecular biology of hereditary diabetes insipidus.
Fujiwara TM; Bichet DG
J Am Soc Nephrol; 2005 Oct; 16(10):2836-46. PubMed ID: 16093448
[TBL] [Abstract][Full Text] [Related]
25. [Identification of mutations in the arginine vasopressin receptor 2 gene in congenital nephrogenic diabetes insipidus patients].
Gu F; Shi Y; Deng J; Jin Z
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1401-5. PubMed ID: 12509923
[TBL] [Abstract][Full Text] [Related]
26. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.
Spanakis E; Milord E; Gragnoli C
J Cell Physiol; 2008 Dec; 217(3):605-17. PubMed ID: 18726898
[TBL] [Abstract][Full Text] [Related]
27. [Nephrogenic diabetes insipidus associated with mutations of vasopressin V2 receptors and aquaporin-2].
Ishikawa SE
Nihon Rinsho; 2002 Feb; 60(2):350-5. PubMed ID: 11857925
[TBL] [Abstract][Full Text] [Related]
28. C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online.
Szalai C; Triga D; Czinner A
Hum Mutat; 1998; 12(2):137-8. PubMed ID: 10694923
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
Makretskaya NA; Nanzanova US; Hamaganova IR; Eremina ER; Tiulpakov AN
Probl Endokrinol (Mosk); 2023 May; 69(2):75-79. PubMed ID: 37448274
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
Neocleous V; Skordis N; Shammas C; Efstathiou E; Mastroyiannopoulos NP; Phylactou LA
Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
[TBL] [Abstract][Full Text] [Related]
31. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
Faerch M; Christensen JH; Corydon TJ; Kamperis K; de Zegher F; Gregersen N; Robertson GL; Rittig S
Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
[TBL] [Abstract][Full Text] [Related]
32. Repulsion between Lys258 and upstream arginines explains the missorting of the AQP2 mutant p.Glu258Lys in nephrogenic diabetes insipidus.
Kamsteeg EJ; Stoffels M; Tamma G; Konings IB; Deen PM
Hum Mutat; 2009 Oct; 30(10):1387-96. PubMed ID: 19701945
[TBL] [Abstract][Full Text] [Related]
33. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
34. [Congenital nephrogenic diabetes insipidus].
Morin D; Delenne AL; Kervran A
Arch Pediatr; 2005 Jan; 12(1):59-66. PubMed ID: 15653057
[TBL] [Abstract][Full Text] [Related]
35. Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.
Tsukaguchi H; Matsubara H; Taketani S; Mori Y; Seido T; Inada M
J Clin Invest; 1995 Oct; 96(4):2043-50. PubMed ID: 7560098
[TBL] [Abstract][Full Text] [Related]
36. Molecular and cellular defects in nephrogenic diabetes insipidus.
Knoers NV; Deen PM
Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
[TBL] [Abstract][Full Text] [Related]
37. [Water metabolism and its disturbances].
Shoji M; Yasujima M
Rinsho Byori; 1999 Dec; 47(12):1121-7. PubMed ID: 10639821
[TBL] [Abstract][Full Text] [Related]
38. Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.
Sasaki S; Chiga M; Kikuchi E; Rai T; Uchida S
Clin Exp Nephrol; 2013 Jun; 17(3):338-44. PubMed ID: 23150186
[TBL] [Abstract][Full Text] [Related]
39. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
Morin D
Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
